- ⚠️ FOR RESEARCH PURPOSES ONLY
- - This product has not been evaluated by the FDA and is not approved for human or veterinary use. Intended solely for laboratory and research applications.
CJC-IPA
GHRH Analog / Ghrelin Receptor Agonist
- $39.99
- In Stock
A GHRH analog paired with a selective ghrelin receptor agonist, studied together for their role in growth hormone secretion pathways in animal and in vitro studies.
Mass
Shipping Protection
If your order is lost or damaged, please email support@tyronstone.softvenceomega.com
2–5 Days Shipping
Third-Party Tested
- We accept :
Certificate of Analysis
Third Party Tested
LATEST ISO 17025
SELECTED DOSAGE
99.81% (HPLC Verified)
PURITY
✓ Passed expanded QC panel
Variant 5mg / 5mg
Lot # VP-CP-260731
Labeled 10 mg
Actual 5.26 mg / 6.19 mg
Tested Aug 25,2026
EXPANDED QC PANEL
Identity (LC-MS)
Confirmed ✓
Purity (HPLC)
99.81% ✓
Fentanyl Screen
Not Detected ✓
Appearance
White Lyophilized Powder ✓
Endotoxin
Pass ✓
Heavy Metals
Within Limits ✓
ISO/IEC 17025 ACCREDITED
Frequently Researched Together
BPC+TB5
- From
- $45.99
A peptide combination studied for its role in tissue repair and wound healing.
Compound Information
Technical specifications
MOLECULAR PROFILE
What Is CJC-IPA?
Type Synthetic GHRH Analog (CJC-1295) + Synthetic Growth Hormone Secretagogue (Ipamorelin)
Molecular Weight 3367.9 g/mol + 711.85 g/mol
Peptide Length 29 AA / 5 AA
Classification CJC-1295 + Ipamorelin
Formula C₁₅₂H₂₅₂N₄₄O₄₂ + C₃₈H₄₉N₉O₅
STORAGE REQUIREMENTS
Stability Information
Keep dry and protected form light Store at stable temperature Avoid repeated freeze-thaw cycles
Lyophilized Powder
-20°C
Reconstituted
2-8°C
